Tpg Gp A »

Apellis Pharmaceuticals shares owned by Tpg Gp A

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Tpg Gp A from 13F filings

Historical chart of Tpg Gp A investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Tpg Gp A consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Tpg Gp A

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0M 50k 40.23

More positions owned by Tpg Gp A

Lifestance Health Group (LFST)
Jackson Financial Com Cl A (JXN)
Life Time Group Holdings Common Stock (LTH)
Sionna Therapeutics (SION)
Beta Technologies Com Shs Cl A (BETA)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Ngl Energy Partners Com Unit Repst (NGL)
Ceribell (CBLL)
Harsco Corporation (NVRI)
Bofa Fin MTNF 0.600% 5/2
Bicara Therapeutics (BCAX)
Evergy Note 4.500%12/1
Starwood Ppty Tr Note 6.750% 7/1
Bruker Corp 6.375 Pref Ser A (BRKRP)
Allogene Therapeutics (ALLO)

View all positions for Tpg Gp A

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals